Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Shares Outstanding (Weighted Average) (2016 - 2025)

Fortress Biotech has reported Shares Outstanding (Weighted Average) over the past 13 years, most recently at $13.4 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Weighted Average) at $13.4 million for Q4 2025, down 6.77% from a year ago — trailing twelve months through Dec 2025 was $13.4 million (down 6.77% YoY), and the annual figure for FY2025 was $13.4 million, down 6.77%.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $13.4 million at Fortress Biotech, down from $27.1 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for FBIO hit a ceiling of $88.7 million in Q2 2022 and a floor of $127288.0 in Q4 2022.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $13.9 million (2024), compared with a mean of $22.2 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): tumbled 97.86% in 2023 and later surged 15373.61% in 2024.
  • Fortress Biotech's Shares Outstanding (Weighted Average) stood at $300374.0 in 2021, then plummeted by 57.62% to $127288.0 in 2022, then surged by 4446.61% to $5.8 million in 2023, then surged by 148.93% to $14.4 million in 2024, then decreased by 6.77% to $13.4 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $13.4 million (Q4 2025), $27.1 million (Q3 2025), and $26.9 million (Q2 2025) per Business Quant data.